DnB Asset Management AS Has $44.52 Million Stock Holdings in Humana Inc. (NYSE:HUM)

DnB Asset Management AS lowered its position in shares of Humana Inc. (NYSE:HUM) by 12.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 175,473 shares of the insurance provider’s stock after selling 24,768 shares during the quarter. DnB Asset Management AS owned 0.15% of Humana worth $44,519,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of HUM. FPC Investment Advisory Inc. acquired a new position in shares of Humana in the 4th quarter valued at $27,000. Centricity Wealth Management LLC acquired a new position in Humana in the fourth quarter valued at about $30,000. LFA Lugano Financial Advisors SA increased its holdings in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new stake in shares of Humana during the fourth quarter worth about $33,000. Finally, Atwood & Palmer Inc. lifted its holdings in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 60 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 0.2 %

Shares of Humana stock opened at $270.04 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business has a fifty day simple moving average of $270.51 and a two-hundred day simple moving average of $274.93. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a market capitalization of $32.59 billion, a price-to-earnings ratio of 27.14, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.31%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Analyst Ratings Changes

HUM has been the topic of several research analyst reports. Royal Bank of Canada restated an “outperform” rating and set a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Barclays upped their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Finally, JPMorgan Chase & Co. dropped their target price on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Eighteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $285.68.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.37% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.